Top compounds associated with response to FXYD6


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.27 1e-13
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.26 5e-12
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.26 1e-11
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.25 2e-11
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.24 6e-11
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.24 1e-10
mRNA PX-12 CTRPv2 pan-cancer AAC 0.19 2e-10
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 2e-10
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.23 5e-10
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.24 1e-08
Download CSV